Ovid Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $81.63K, a 84.73% decline year-over-year.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $109.55K, a 16.16% decline year-over-year.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $33.08K, a 78.09% decline year-over-year.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $534.59K, a 357.38% increase year-over-year.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $807.47K, a 168.42% increase from fiscal 2020.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $300.82K.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $111.38K, a 311.86% increase from fiscal 2017.
- Ovid Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $27.04K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-09-30 | $81.63K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $109.55K 10-Q · filed 2022-11-08 | |
| 2022-03-31 | $33.08K 10-Q · filed 2022-11-08 | |
| 2021-12-31 | $807.47K 10-K · filed 2022-03-15 | |
| 2021-09-30 | $534.59K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $130.66K 10-Q · filed 2021-11-10 | |
| 2021-03-31 | $150.97K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $300.82K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $116.88K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $160.94K 10-Q · filed 2021-11-10 | |
| 2018-12-31 | $111.38K 10-K · filed 2020-03-11 | |
| 2018-06-30 | $98.70K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $12.68K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $27.04K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |